1 Min Read
Dec 1 (Reuters) - Intelgenx Technologies Corp
* Intelgenx Technologies says signs term sheet with Chemo Group for co-development and commercialization of a generic tablet in area of CNS Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.